These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20566962)

  • 1. Letter by Lin et al regarding article, "Heart rate predicts outcomes in an implantable cardioverter-defibrillator population".
    Lin GM; Chu KM; Han CL
    Circulation; 2010 Jun; 121(24):e450; author reply e452. PubMed ID: 20566962
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Fazio and Carlomagno regarding article, "Heart rate predicts outcomes in an implantable cardioverter-defibrillator population".
    Fazio S; Carlomagno G
    Circulation; 2010 Jun; 121(24):e451; author reply e452. PubMed ID: 20566963
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator.
    Moss AJ
    Circulation; 2005 May; 111(19):2537-49; discussion 2537-49. PubMed ID: 15900623
    [No Abstract]   [Full Text] [Related]  

  • 5. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator.
    Buxton AE
    Circulation; 2005 May; 111(19):2537-49; discussion 2537-49. PubMed ID: 15897357
    [No Abstract]   [Full Text] [Related]  

  • 6. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontiers in congestive heart failure: initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
    Tepper D
    Congest Heart Fail; 2002; 8(2):91. PubMed ID: 11927784
    [No Abstract]   [Full Text] [Related]  

  • 8. Predicting outcome after implantable cardioverter-defibrillator therapy: a new piece to the puzzle?
    Shepard RK; Ellenbogen KA
    J Am Coll Cardiol; 2009 Aug; 54(9):829-31. PubMed ID: 19695462
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of death: implantable cardioverter defibrillators and proactive care.
    Sears SF; Sowell LV; Kuhl EA; Handberg EM; Kron J; Aranda JM; Conti JB
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):637-42. PubMed ID: 16784431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Ahn C; Tsai FS; Lai HM; Gandhi K; Amin H; Frishman WH; Kalapatapu K; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):37-40. PubMed ID: 19966176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--For].
    Klein HU
    Dtsch Med Wochenschr; 2006 Apr; 131(14):772. PubMed ID: 16596499
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic capabilities of devices for cardiac resynchronization therapy.
    Gardini A; Lupo P; Zanelli E; Bisetti S; Cappato R
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):186-9. PubMed ID: 19829134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate predicts outcomes in an implantable cardioverter-defibrillator population.
    Ahmadi-Kashani M; Kessler DJ; Day J; Bunch TJ; Stolen KQ; Brown S; Sbaity S; Olshansky B;
    Circulation; 2009 Nov; 120(21):2040-5. PubMed ID: 19901194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy".
    Madias JE
    Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15900622
    [No Abstract]   [Full Text] [Related]  

  • 15. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy".
    Jachuck M; Satchithananda DK
    Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15897353
    [No Abstract]   [Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications to implantable cardioverter defibrillator in heart failure patients: a comment on the recently released ESC Guidelines on treatment and diagnosis of heart failure.
    Gasparini M; Breithardt G
    Eur Heart J; 2005 Nov; 26(22):2472-3; author reply 2473-4. PubMed ID: 16204261
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator.
    Daubert JC; Leclercq C; Mabo P
    Europace; 2009 Nov; 11 Suppl 5():v87-92. PubMed ID: 19861397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--Against].
    Ertl G; Bauer W
    Dtsch Med Wochenschr; 2006 Apr; 131(14):773. PubMed ID: 16596500
    [No Abstract]   [Full Text] [Related]  

  • 20. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS
    Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.